Project Grant R21MH141410
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Miami a Project Grant totaling $731,258 on March 1, 2026, under the Mental Health Research Grants program (CFDA 93.242). The award supports a longitudinal neuroimaging research study investigating the neural dynamics underlying internalizing disorders, specifically Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). The research leverages high-stakes, real-world...
- This federal Project Grant award of $774,632 was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The award supports research to understand how changes in dopamine signaling impact neural circuits and contribute to symptoms like impaired cognition and perception in dopamine-associated neuropsychiatric diseases. The key objectives are to use in vivo imaging to determine how selectively activating dopamine neurons in the...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the Regents of the University of Michigan a $3.97 million Project Grant (CFDA 93.242 - Mental Health Research Grants) effective August 1, 2025, through July 31, 2028, to develop a scalable high-plex pipeline for whole-brain proteomics profiling. The project addresses a critical gap in neuroscience research by creating a comprehensive proteomics atlas of the mammalian brain, complementing existing transcriptomics...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $2.9 million to the Regents of the University of Michigan under the Mental Health Research Grants program (CFDA 93.242) on September 22, 2025, for a four-year project period extending through September 21, 2029. This Project Grant supports basic neuroscience research investigating the neural mechanisms underlying associative learning, with a focus on identifying how midbrain signals contribute to differential...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Virginia a $768,909 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective May 1, 2025, through January 31, 2030. This research initiative, titled "Synchronous Network Activity in the Maturing Prefrontal Cortex: Mechanistic Impact of Birth Timing and Serotonin," investigates how premature birth affects brain development and cognitive function. The...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded The University of Iowa a Project Grant totaling $732,635 under the Mental Health Research Grants program (CFDA 93.242) to investigate mediodorsal (MD) thalamus representations underlying human cognitive flexibility. The research, initiated September 19, 2025, and scheduled for completion by July 31, 2030, employs a computational cognitive neuroscience approach integrating computational models with...
- Federal Project Grant Award Summary The University of California, San Diego received a $415,664 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 15, 2026, with a completion date of December 31, 2030. This award supports a research project investigating the dissociable roles of distinct orbitostriatal circuits in value-based decision-making. The research employs advanced neuroscientific...
- Federal Grant Award Summary New York University received a $710,563 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 5, 2026, with a completion date of November 30, 2030. The award supports fundamental neuroscience research investigating the neural circuit mechanisms underlying dynamic learning rates in reinforcement learning. The research will determine how orbitofrontal cortex (OFC) projections...
- Federal Grant Award Summary The Medical College of Wisconsin, Inc. received a $521,266 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 15, 2026, with a completion date of January 31, 2031. This award supports basic neuroscience research investigating the role of mechanistic target of rapamycin (mTOR) signaling in midbrain dopamine neurons and its relationship to hyperactivity and impulsivity...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (RFMH) under the Mental Health Research Grants program (CFDA 93.242) beginning August 1, 2025, with a completion date of July 31, 2030. This project grant funds a five-year clinical research investigation examining the role of the anterior hippocampus in the pathogenesis of major depressive disorder (MDD). The research leverages functional magnetic...
The National Institute of Mental Health (NIMH) awarded $409,750 to the University of Alabama at Birmingham under the Mental Health Research Grants program (CFDA 93.242) on March 15, 2026, for a two-year research project concluding March 14, 2028. This project grant funds fundamental neuroscience research investigating the role of localized dopamine signals in learning and neural circuit function. The research employs two-photon microscopy and genetically encoded sensors to simultaneously track dopamine release and neuronal activity in real-time as laboratory mice perform neuroprosthetic control tasks, enabling researchers to directly identify task-relevant neurons and determine whether dopamine modulation occurs at the single-neuron level or across broader neural networks. The research deliverables include empirical findings on dopamine's spatial specificity in shaping learning processes and the mechanisms by which this neuromodulator influences neural circuits. These outcomes are designed to advance fundamental understanding of brain mechanisms underlying learning and to elucidate how dopamine signaling disruptions contribute to psychiatric conditions including depression, schizophrenia, and addiction. The project's findings are expected to support development of more targeted therapeutic interventions focusing on dopamine-related brain circuits for treatment of cognitive dysfunction and mental health disorders, thereby advancing the NIMH mission to transform understanding and treatment of mental illnesses through basic and clinical research.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $409.8k | 3/6/26 |